Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 36701 - 36725 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Entinostat	Investigational	CCDC153	283152	upregulated	entinostat results in increased expression of CCDC153 mRNA	11q23.3	A21035
Entinostat	Investigational	CCDC177	56936	downregulated	entinostat results in decreased expression of CCDC177 mRNA	14q24.1	A21037
Entinostat	Investigational	CCDC50	152137	downregulated	entinostat results in decreased expression of CCDC50 mRNA	3q28	A21037
Entinostat	Investigational	CCDC69	26112	upregulated	entinostat results in increased expression of CCDC69 mRNA	5q33.1	A21037 A21035
Entinostat	Investigational	CCDC80	151887	downregulated	entinostat results in decreased expression of CCDC80 mRNA	3q13.2	A21037
Entinostat	Investigational	CCDC92	80212	downregulated	entinostat results in decreased expression of CCDC92 mRNA	12q24.31	A21037
Entinostat	Investigational	CCDC92	80212	upregulated	entinostat results in increased expression of CCDC92 mRNA	12q24.31	A21035
Entinostat	Investigational	CCKBR	887	downregulated	entinostat results in decreased expression of CCKBR mRNA	11p15.4	A21037
Entinostat	Investigational	CCL2	6347	upregulated	entinostat results in increased expression of CCL2 mRNA	17q12	A21035
Entinostat	Investigational	CCL26	10344	upregulated	entinostat results in increased expression of CCL26 mRNA	7q11.23	A21037 A21035
Entinostat	Investigational	CCM2L	140706	upregulated	entinostat results in increased expression of CCM2L mRNA	20q11.21	A21037 A21035
Entinostat	Investigational	CCND1	595	upregulated	entinostat results in increased expression of CCND1 mRNA	11q13.3	A21037
Entinostat	Investigational	CCNE2	9134	downregulated	entinostat results in decreased expression of CCNE2 mRNA	8q22.1	A21037 A21035
Entinostat	Investigational	CCNG2	901	downregulated	entinostat results in decreased expression of CCNG2 mRNA	4q21.1	A21037
Entinostat	Investigational	CCNJ	54619	downregulated	entinostat results in decreased expression of CCNJ mRNA	10q24.1	A21035
Entinostat	Investigational	CCNT1	904	downregulated	entinostat results in decreased expression of CCNT1 mRNA	12q13.11-q13.12	A21035
Entinostat	Investigational	CCNT2	905	downregulated	entinostat results in decreased expression of CCNT2 mRNA	2q21.3	A21037
Entinostat	Investigational	CCR10	2826	upregulated	entinostat results in increased expression of CCR10 mRNA	17q21.2	A21035
Entinostat	Investigational	CD109	135228	upregulated	entinostat results in increased expression of CD109 mRNA	6q13	A21037 A21035
Entinostat	Investigational	CD19	930	upregulated	entinostat results in increased expression of CD19 mRNA	16p11.2	A21037
Entinostat	Investigational	CD200	4345	downregulated	entinostat results in decreased expression of CD200 mRNA	3q13.2	A21035
Entinostat	Investigational	CD24	100133941	upregulated	entinostat results in increased expression of CD24 mRNA	6q21	A21037
Entinostat	Investigational	CD302	9936	upregulated	entinostat results in increased expression of CD302 mRNA	2q24.2	A21035
Entinostat	Investigational	CD36	948	upregulated	entinostat results in increased expression of CD36 mRNA	7q21.11	A21035
Entinostat	Investigational	CD40	958	upregulated	entinostat results in increased expression of CD40 mRNA	20q13.12	A21035

Displaying entries 36701 - 36725 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability